These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38087763)

  • 1. Retraction notice to "Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine" [Journal of the Neurological Sciences 202 (2002), 65-68].
    Sato Y; Kaji M; Kondo I; Yoshida H; Satoh K; Metoki N
    J Neurol Sci; 2024 Jan; 456():122820. PubMed ID: 38087763
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine.
    Sato Y; Kaji M; Kondo I; Yoshida H; Satoh K; Metoki N
    J Neurol Sci; 2002 Oct; 202(1-2):65-8. PubMed ID: 12220694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
    Kalita J; Kumar G; Bansal V; Misra UK
    Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to "Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients" [Journal of the Neurological Sciences 231 (2005), 13-18].
    Sato Y; Honda Y; Iwamoto J; Kanoko T; Satoh K
    J Neurol Sci; 2024 Jan; 456():122819. PubMed ID: 38087761
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke" [Journal of the Neurological Sciences 156 (1998), 205-210].
    Sato Y; Fujimatsu Y; Kikuyama M; Kaji M; Oizumic K
    J Neurol Sci; 2024 Jan; 456():122824. PubMed ID: 38087764
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke" [Journal of the Neurological Sciences 175 (2000), 135-139].
    Sato Y; Kuno H; Kaji M; Etoh K; Oizumi K
    J Neurol Sci; 2024 Jan; 456():122822. PubMed ID: 38072682
    [No Abstract]   [Full Text] [Related]  

  • 7. Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients.
    Karakurum Goksel B; Karatas M; Nebioglu A; Sezgin N; Tan M; Seydaoglu G; Benli S; Karaca S; Arlier Z; Yerdelen D
    Neurol Res; 2007 Dec; 29(8):871-6. PubMed ID: 17588311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia induced locked-in syndrome in a young adult due to folic acid deficiency.
    Sonkar SK; Kumar S; Singh NK; Tandon R
    Nutr Neurosci; 2021 Oct; 24(10):781-783. PubMed ID: 31642398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying gene-environment interactions on the efficacy of folic acid therapy for hyperhomocysteinemia based on prediction model.
    Zhao Q; Li D; Huang X; Ren B; Yue L; Du B; Zhang C; Zhang W
    Nutr Res; 2020 May; 77():54-61. PubMed ID: 32320840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?
    Maron BA; Loscalzo J
    Curr Atheroscler Rep; 2007 Nov; 9(5):375-83. PubMed ID: 18001620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents" [Journal of the Neurological Sciences 212 (2003), 55-58].
    Sato Y; Kaji M; Metoki N; Yoshida H; Satoh K
    J Neurol Sci; 2024 Jan; 456():122818. PubMed ID: 38087762
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "Risk factors for hip fracture among elderly patients with Parkinson's disease" [Journal of the Neurological Sciences 182 (2001), 89-93].
    Sato Y; Kaji M; Tsuru T; Oizumi K
    J Neurol Sci; 2024 Jan; 456():122821. PubMed ID: 38087765
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Risk factors for hip fracture among elderly patients with Alzheimer's disease" [Journal of the Neurological Sciences 223 (2004), 107-112].
    Sato Y; Kanoko T; Satoh K; Iwamoto J
    J Neurol Sci; 2024 Jan; 456():122823. PubMed ID: 38044180
    [No Abstract]   [Full Text] [Related]  

  • 14. Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension.
    Singh Y; Samuel VP; Dahiya S; Gupta G; Gillhotra R; Mishra A; Singh M; SreeHarsha N; Gubbiyappa SK; Tambuwala MM; Chellappan DK; Dua K
    Biotechnol Appl Biochem; 2019 Sep; 66(5):715-719. PubMed ID: 31314127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leg ulcers due to hyperhomocysteinemia.
    Krupa Shankar DS; Akhib S
    Indian J Dermatol Venereol Leprol; 2006; 72(5):367-9. PubMed ID: 17050933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
    Sunder-Plassmann G; Födinger M; Buchmayer H; Papagiannopoulos M; Wojcik J; Kletzmayr J; Enzenberger B; Janata O; Winkelmayer WC; Paul G; Auinger M; Barnas U; Hörl WH
    J Am Soc Nephrol; 2000 Jun; 11(6):1106-1116. PubMed ID: 10820175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic stroke and hyperhomocysteinemia: truth or myth?
    Terwecoren A; Steen E; Benoit D; Boon P; Hemelsoet D
    Acta Neurol Belg; 2009 Sep; 109(3):181-8. PubMed ID: 19902811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Folic Acid Therapy in Patients with Hyperhomocysteinemia.
    Tian H; Tian D; Zhang C; Wang W; Wang L; Ge M; Hou Q; Zhang W
    J Am Coll Nutr; 2017; 36(7):528-532. PubMed ID: 28854002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
    Hwang SY; Siow YL; Au-Yeung KK; House J; O K
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.